Global Smallpox Vaccine Market Insights and Forecast to 2031

Report ID: 1534273 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Smallpox Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Smallpox Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 First Generation
        1.2.3 Second Generation
        1.2.4 Third Generation
    1.3 Market by Application
        1.3.1 Global Smallpox Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Government Hospital And Program
        1.3.3 Private Hospitals / Clinicss
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Smallpox Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Smallpox Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Smallpox Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Smallpox Vaccine Sales by Region
        2.4.1 Global Smallpox Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Smallpox Vaccine by Region (2023-2028)
    2.5 Global Smallpox Vaccine Revenue by Region
        2.5.1 Global Smallpox Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Smallpox Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Smallpox Vaccine Sales by Manufacturers
        3.1.1 Global Top Smallpox Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Smallpox Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Smallpox Vaccine in 2021
    3.2 Global Smallpox Vaccine Revenue by Manufacturers
        3.2.1 Global Smallpox Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Smallpox Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Smallpox Vaccine Revenue in 2021
    3.3 Global Smallpox Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Smallpox Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Smallpox Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Smallpox Vaccine Sales by Type
        4.1.1 Global Smallpox Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Smallpox Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Smallpox Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Smallpox Vaccine Revenue by Type
        4.2.1 Global Smallpox Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Smallpox Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Smallpox Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Smallpox Vaccine Price by Type
        4.3.1 Global Smallpox Vaccine Price by Type (2017-2022)
        4.3.2 Global Smallpox Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Smallpox Vaccine Sales by Application
        5.1.1 Global Smallpox Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Smallpox Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Smallpox Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Smallpox Vaccine Revenue by Application
        5.2.1 Global Smallpox Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Smallpox Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Smallpox Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Smallpox Vaccine Price by Application
        5.3.1 Global Smallpox Vaccine Price by Application (2017-2022)
        5.3.2 Global Smallpox Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Smallpox Vaccine Market Size by Type
        6.1.1 North America Smallpox Vaccine Sales by Type (2017-2028)
        6.1.2 North America Smallpox Vaccine Revenue by Type (2017-2028)
    6.2 North America Smallpox Vaccine Market Size by Application
        6.2.1 North America Smallpox Vaccine Sales by Application (2017-2028)
        6.2.2 North America Smallpox Vaccine Revenue by Application (2017-2028)
    6.3 North America Smallpox Vaccine Market Size by Country
        6.3.1 North America Smallpox Vaccine Sales by Country (2017-2028)
        6.3.2 North America Smallpox Vaccine Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Smallpox Vaccine Market Size by Type
        7.1.1 Europe Smallpox Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Smallpox Vaccine Revenue by Type (2017-2028)
    7.2 Europe Smallpox Vaccine Market Size by Application
        7.2.1 Europe Smallpox Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Smallpox Vaccine Revenue by Application (2017-2028)
    7.3 Europe Smallpox Vaccine Market Size by Country
        7.3.1 Europe Smallpox Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Smallpox Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Smallpox Vaccine Market Size by Type
        8.1.1 Asia Pacific Smallpox Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Smallpox Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Smallpox Vaccine Market Size by Application
        8.2.1 Asia Pacific Smallpox Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Smallpox Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Smallpox Vaccine Market Size by Region
        8.3.1 Asia Pacific Smallpox Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Smallpox Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Smallpox Vaccine Market Size by Type
        9.1.1 Latin America Smallpox Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Smallpox Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Smallpox Vaccine Market Size by Application
        9.2.1 Latin America Smallpox Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Smallpox Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Smallpox Vaccine Market Size by Country
        9.3.1 Latin America Smallpox Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Smallpox Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Smallpox Vaccine Market Size by Type
        10.1.1 Middle East and Africa Smallpox Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Smallpox Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Smallpox Vaccine Market Size by Application
        10.2.1 Middle East and Africa Smallpox Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Smallpox Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Smallpox Vaccine Market Size by Country
        10.3.1 Middle East and Africa Smallpox Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Smallpox Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bavarian Nordic
        11.1.1 Bavarian Nordic Corporation Information
        11.1.2 Bavarian Nordic Overview
        11.1.3 Bavarian Nordic Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bavarian Nordic Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bavarian Nordic Recent Developments
    11.2 CEL-SCI
        11.2.1 CEL-SCI Corporation Information
        11.2.2 CEL-SCI Overview
        11.2.3 CEL-SCI Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 CEL-SCI Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 CEL-SCI Recent Developments
    11.3 Chimerix
        11.3.1 Chimerix Corporation Information
        11.3.2 Chimerix Overview
        11.3.3 Chimerix Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Chimerix Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Chimerix Recent Developments
    11.4 EpiVax
        11.4.1 EpiVax Corporation Information
        11.4.2 EpiVax Overview
        11.4.3 EpiVax Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 EpiVax Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 EpiVax Recent Developments
    11.5 Nanotherapeutics
        11.5.1 Nanotherapeutics Corporation Information
        11.5.2 Nanotherapeutics Overview
        11.5.3 Nanotherapeutics Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Nanotherapeutics Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Nanotherapeutics Recent Developments
    11.6 Oncovir
        11.6.1 Oncovir Corporation Information
        11.6.2 Oncovir Overview
        11.6.3 Oncovir Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Oncovir Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Oncovir Recent Developments
    11.7 SIGA Technologies
        11.7.1 SIGA Technologies Corporation Information
        11.7.2 SIGA Technologies Overview
        11.7.3 SIGA Technologies Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 SIGA Technologies Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 SIGA Technologies Recent Developments
    11.8 Symphogen
        11.8.1 Symphogen Corporation Information
        11.8.2 Symphogen Overview
        11.8.3 Symphogen Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Symphogen Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Symphogen Recent Developments
    11.9 TapImmune
        11.9.1 TapImmune Corporation Information
        11.9.2 TapImmune Overview
        11.9.3 TapImmune Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 TapImmune Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 TapImmune Recent Developments
    11.10 Tonix Pharmaceuticals Holding
        11.10.1 Tonix Pharmaceuticals Holding Corporation Information
        11.10.2 Tonix Pharmaceuticals Holding Overview
        11.10.3 Tonix Pharmaceuticals Holding Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Tonix Pharmaceuticals Holding Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Tonix Pharmaceuticals Holding Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Smallpox Vaccine Industry Chain Analysis
    12.2 Smallpox Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Smallpox Vaccine Production Mode & Process
    12.4 Smallpox Vaccine Sales and Marketing
        12.4.1 Smallpox Vaccine Sales Channels
        12.4.2 Smallpox Vaccine Distributors
    12.5 Smallpox Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Smallpox Vaccine Industry Trends
    13.2 Smallpox Vaccine Market Drivers
    13.3 Smallpox Vaccine Market Challenges
    13.4 Smallpox Vaccine Market Restraints
14 Key Findings in The Global Smallpox Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Smallpox Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of First Generation
    Table 3. Major Manufacturers of Second Generation
    Table 4. Major Manufacturers of Third Generation
    Table 5. Global Smallpox Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Smallpox Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Smallpox Vaccine Sales by Region (2017-2022) & (K Units)
    Table 8. Global Smallpox Vaccine Sales Market Share by Region (2017-2022)
    Table 9. Global Smallpox Vaccine Sales by Region (2023-2028) & (K Units)
    Table 10. Global Smallpox Vaccine Sales Market Share by Region (2023-2028)
    Table 11. Global Smallpox Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Smallpox Vaccine Revenue Market Share by Region (2017-2022)
    Table 13. Global Smallpox Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Smallpox Vaccine Revenue Market Share by Region (2023-2028)
    Table 15. Global Smallpox Vaccine Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Smallpox Vaccine Sales Share by Manufacturers (2017-2022)
    Table 17. Global Smallpox Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Smallpox Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 19. Smallpox Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Smallpox Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Smallpox Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Smallpox Vaccine as of 2021)
    Table 22. Smallpox Vaccine Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Smallpox Vaccine Product Offered
    Table 24. Date of Manufacturers Enter into Smallpox Vaccine Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Smallpox Vaccine Sales by Type (2017-2022) & (K Units)
    Table 27. Global Smallpox Vaccine Sales by Type (2023-2028) & (K Units)
    Table 28. Global Smallpox Vaccine Sales Share by Type (2017-2022)
    Table 29. Global Smallpox Vaccine Sales Share by Type (2023-2028)
    Table 30. Global Smallpox Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Smallpox Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Smallpox Vaccine Revenue Share by Type (2017-2022)
    Table 33. Global Smallpox Vaccine Revenue Share by Type (2023-2028)
    Table 34. Smallpox Vaccine Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Smallpox Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Smallpox Vaccine Sales by Application (2017-2022) & (K Units)
    Table 37. Global Smallpox Vaccine Sales by Application (2023-2028) & (K Units)
    Table 38. Global Smallpox Vaccine Sales Share by Application (2017-2022)
    Table 39. Global Smallpox Vaccine Sales Share by Application (2023-2028)
    Table 40. Global Smallpox Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Smallpox Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Smallpox Vaccine Revenue Share by Application (2017-2022)
    Table 43. Global Smallpox Vaccine Revenue Share by Application (2023-2028)
    Table 44. Smallpox Vaccine Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Smallpox Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Smallpox Vaccine Sales by Type (2017-2022) & (K Units)
    Table 47. North America Smallpox Vaccine Sales by Type (2023-2028) & (K Units)
    Table 48. North America Smallpox Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Smallpox Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Smallpox Vaccine Sales by Application (2017-2022) & (K Units)
    Table 51. North America Smallpox Vaccine Sales by Application (2023-2028) & (K Units)
    Table 52. North America Smallpox Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Smallpox Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Smallpox Vaccine Sales by Country (2017-2022) & (K Units)
    Table 55. North America Smallpox Vaccine Sales by Country (2023-2028) & (K Units)
    Table 56. North America Smallpox Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Smallpox Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Smallpox Vaccine Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Smallpox Vaccine Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Smallpox Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Smallpox Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Smallpox Vaccine Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Smallpox Vaccine Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Smallpox Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Smallpox Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Smallpox Vaccine Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Smallpox Vaccine Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Smallpox Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Smallpox Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Smallpox Vaccine Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Smallpox Vaccine Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Smallpox Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Smallpox Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Smallpox Vaccine Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Smallpox Vaccine Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Smallpox Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Smallpox Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Smallpox Vaccine Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Smallpox Vaccine Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Smallpox Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Smallpox Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Smallpox Vaccine Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Smallpox Vaccine Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Smallpox Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Smallpox Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Smallpox Vaccine Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Smallpox Vaccine Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Smallpox Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Smallpox Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Smallpox Vaccine Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Smallpox Vaccine Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Smallpox Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Smallpox Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Smallpox Vaccine Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Smallpox Vaccine Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Smallpox Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Smallpox Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Smallpox Vaccine Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Smallpox Vaccine Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Smallpox Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Smallpox Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Smallpox Vaccine Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Smallpox Vaccine Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Smallpox Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Smallpox Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Bavarian Nordic Corporation Information
    Table 107. Bavarian Nordic Description and Major Businesses
    Table 108. Bavarian Nordic Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Bavarian Nordic Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Bavarian Nordic Recent Developments
    Table 111. CEL-SCI Corporation Information
    Table 112. CEL-SCI Description and Major Businesses
    Table 113. CEL-SCI Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. CEL-SCI Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. CEL-SCI Recent Developments
    Table 116. Chimerix Corporation Information
    Table 117. Chimerix Description and Major Businesses
    Table 118. Chimerix Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Chimerix Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Chimerix Recent Developments
    Table 121. EpiVax Corporation Information
    Table 122. EpiVax Description and Major Businesses
    Table 123. EpiVax Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. EpiVax Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. EpiVax Recent Developments
    Table 126. Nanotherapeutics Corporation Information
    Table 127. Nanotherapeutics Description and Major Businesses
    Table 128. Nanotherapeutics Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Nanotherapeutics Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Nanotherapeutics Recent Developments
    Table 131. Oncovir Corporation Information
    Table 132. Oncovir Description and Major Businesses
    Table 133. Oncovir Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Oncovir Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Oncovir Recent Developments
    Table 136. SIGA Technologies Corporation Information
    Table 137. SIGA Technologies Description and Major Businesses
    Table 138. SIGA Technologies Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. SIGA Technologies Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. SIGA Technologies Recent Developments
    Table 141. Symphogen Corporation Information
    Table 142. Symphogen Description and Major Businesses
    Table 143. Symphogen Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Symphogen Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Symphogen Recent Developments
    Table 146. TapImmune Corporation Information
    Table 147. TapImmune Description and Major Businesses
    Table 148. TapImmune Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. TapImmune Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. TapImmune Recent Developments
    Table 151. Tonix Pharmaceuticals Holding Corporation Information
    Table 152. Tonix Pharmaceuticals Holding Description and Major Businesses
    Table 153. Tonix Pharmaceuticals Holding Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Tonix Pharmaceuticals Holding Smallpox Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Tonix Pharmaceuticals Holding Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. Smallpox Vaccine Distributors List
    Table 159. Smallpox Vaccine Customers List
    Table 160. Smallpox Vaccine Market Trends
    Table 161. Smallpox Vaccine Market Drivers
    Table 162. Smallpox Vaccine Market Challenges
    Table 163. Smallpox Vaccine Market Restraints
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Smallpox Vaccine Product Picture
    Figure 3. Global Smallpox Vaccine Market Share by Type in 2021 & 2028
    Figure 3. First Generation Product Picture
    Figure 4. Second Generation Product Picture
    Figure 5. Third Generation Product Picture
    Figure 6. Global Smallpox Vaccine Market Share by Application in 2021 & 2028
    Figure 7. Government Hospital And Program
    Figure 8. Private Hospitals / Clinicss
    Figure 9. Smallpox Vaccine Report Years Considered
    Figure 10. Global Smallpox Vaccine Sales 2017-2028 (K Units)
    Figure 11. Global Smallpox Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Smallpox Vaccine Revenue 2017-2028 (US$ Million)
    Figure 13. Global Smallpox Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Smallpox Vaccine Sales Market Share by Region (2017-2022)
    Figure 15. Global Smallpox Vaccine Sales Market Share by Region (2023-2028)
    Figure 16. North America Smallpox Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Smallpox Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Smallpox Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Smallpox Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Smallpox Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Smallpox Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Smallpox Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Smallpox Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Smallpox Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Smallpox Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Smallpox Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Smallpox Vaccine in the World: Market Share by Smallpox Vaccine Revenue in 2021
    Figure 28. Global Smallpox Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Smallpox Vaccine Sales Market Share by Type (2017-2028)
    Figure 30. Global Smallpox Vaccine Revenue Market Share by Type (2017-2028)
    Figure 31. Global Smallpox Vaccine Sales Market Share by Application (2017-2028)
    Figure 32. Global Smallpox Vaccine Revenue Market Share by Application (2017-2028)
    Figure 33. North America Smallpox Vaccine Sales Market Share by Type (2017-2028)
    Figure 34. North America Smallpox Vaccine Revenue Market Share by Type (2017-2028)
    Figure 35. North America Smallpox Vaccine Sales Market Share by Application (2017-2028)
    Figure 36. North America Smallpox Vaccine Revenue Market Share by Application (2017-2028)
    Figure 37. North America Smallpox Vaccine Sales Share by Country (2017-2028)
    Figure 38. North America Smallpox Vaccine Revenue Share by Country (2017-2028)
    Figure 39. U.S. Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Smallpox Vaccine Sales Market Share by Type (2017-2028)
    Figure 42. Europe Smallpox Vaccine Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Smallpox Vaccine Sales Market Share by Application (2017-2028)
    Figure 44. Europe Smallpox Vaccine Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Smallpox Vaccine Sales Share by Country (2017-2028)
    Figure 46. Europe Smallpox Vaccine Revenue Share by Country (2017-2028)
    Figure 47. Germany Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. France Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Smallpox Vaccine Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Smallpox Vaccine Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Smallpox Vaccine Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Smallpox Vaccine Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Smallpox Vaccine Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Smallpox Vaccine Revenue Share by Region (2017-2028)
    Figure 58. China Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. India Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Smallpox Vaccine Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Smallpox Vaccine Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Smallpox Vaccine Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Smallpox Vaccine Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Smallpox Vaccine Sales Share by Country (2017-2028)
    Figure 73. Latin America Smallpox Vaccine Revenue Share by Country (2017-2028)
    Figure 74. Mexico Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Smallpox Vaccine Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Smallpox Vaccine Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Smallpox Vaccine Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Smallpox Vaccine Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Smallpox Vaccine Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Smallpox Vaccine Revenue Share by Country (2017-2028)
    Figure 83. Turkey Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Smallpox Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 86. Smallpox Vaccine Value Chain
    Figure 87. Smallpox Vaccine Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bavarian Nordic
CEL-SCI
Chimerix
EpiVax
Nanotherapeutics
Oncovir
SIGA Technologies
Symphogen
TapImmune
Tonix Pharmaceuticals Holding
Frequently Asked Questions
Smallpox Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Smallpox Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Smallpox Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Smart Battery

Smart Battery market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More